| Protein | Protein Name | Molecular Type | Hallmark | Feature | Evidence | Reference |
|---|
| MET | Met proto-oncogene | Receptor Tyrosine Kinase | Tumour Microenvironment | Cancer Microenvironment | c-MET is involved in the regulations tumour infiltration in surrounding malignant tissues by acquisition of a stem-like phenotype. | Reference |
| MET | Met proto-oncogene | Receptor Tyrosine Kinase | Self-Sufficiency in Growth Signal | Cell Growth | HGF and c-MET is involved in androgen independent prostate cancer cell growth in CWR22R prostate cancer cell line. | Reference |
| MET | Met proto-oncogene | Receptor Tyrosine Kinase | Tumor Promoting Inflammation | Inflammation pathway | c-MET is associated with prostate cancer inflammation. | Reference |
| MET | Met proto-oncogene | Receptor Tyrosine Kinase | Genome Instability, Mutation & Perturbation | Overexpression | c-MET is overexpressed in human prostate cancer and is associated with dedifferentiation of prostate adenocarcinoma. | Reference |
| MET | Met proto-oncogene | Receptor Tyrosine Kinase | Angiogenesis | Angiogenesis | c-MET is associated with induction of angiogenesis through its effects on microvessel density of human prostate cancer. | Reference |
| MET | Met proto-oncogene | Receptor Tyrosine Kinase | Metastasis | Metastasis | HGF and its receptor c-MET is involved in metastasis and invasion in DU145 prostate cancer cell line. | Reference |
| MET | Met proto-oncogene | Receptor Tyrosine Kinase | Metastasis | Cell Invasion | c-MET is associated with sttromal invasion of prostate cancer. | Reference |
| MET | Met proto-oncogene | Receptor Tyrosine Kinase | Metastasis | Cell Migration | c-MET is involved in prostate cancer cell migration in DU-145 prostate cancer cells. | Reference |
| MET | Met proto-oncogene | Receptor Tyrosine Kinase | Metastasis | Bone Metastasis | c-MET is involved in bone metastasis in human prostate cancer. | Reference |
| MET | Met proto-oncogene | Receptor Tyrosine Kinase | Castration Resistance | Castration Resistance | MET, a receptor tyrosine kinase plays a very critical role in the castration resistant prostate cancer (CRPC) cell growth through activation of SOX9 and CTNNB1. | Reference |